{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:53:04Z","timestamp":1764276784394,"version":"3.40.5"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1053\/j.ackd.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T01:16:24Z","timestamp":1429578984000},"page":"185-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension"],"prefix":"10.1053","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-7905","authenticated-orcid":false,"given":"Sivakumar","family":"Ardhanari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Kannuswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Lockette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib2","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"issue":"9","key":"10.1053\/j.ackd.2015.03.002_bib3","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.numecd.2013.09.009","article-title":"Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment","volume":"24","author":"Turchi","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies\u2014a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.ackd.2015.03.002_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-5-9","article-title":"Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism","volume":"5","author":"Amar","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0002-9343(65)90122-1","article-title":"Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy","volume":"39","author":"Ross","year":"1965","journal-title":"Am J Med"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jcem-58-5-783","article-title":"Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism","volume":"58","author":"Banks","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/0002-9343(55)90163-7","article-title":"Adrenal cortical carcinoma producing solely mineralocorticoid effect","volume":"19","author":"Foye","year":"1955","journal-title":"Am J Med"},{"issue":"22","key":"10.1053\/j.ackd.2015.03.002_bib12","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","article-title":"Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling","volume":"51","author":"Omura","year":"2002","journal-title":"Metabolism"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2014-3663","article-title":"Update in primary aldosteronism","volume":"100","author":"Stowasser","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6018","key":"10.1053\/j.ackd.2015.03.002_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib17","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/EJE-12-0813","article-title":"Genetics of mineralocorticoid excess: an update for clinicians","volume":"169","author":"Zennaro","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.002_bib18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib20","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1053\/j.ackd.2015.03.002_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2002-23491","article-title":"Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism","volume":"110","author":"Trenkel","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.002_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.acvd.2012.07.006","article-title":"Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: a multicentre study","volume":"105","author":"Ducher","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/HYPERTENSIONAHA.114.04812","article-title":"Influence of diagnostic criteria on the interpretation of adrenal vein sampling","volume":"65","author":"Lethielleux","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI110565","article-title":"Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease","volume":"69","author":"Chrousos","year":"1982","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib28","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2008-0040","article-title":"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder","volume":"93","author":"Charmandari","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5476","key":"10.1053\/j.ackd.2015.03.002_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","article-title":"Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction","volume":"19","author":"Gordon","year":"1970","journal-title":"Australas Ann Med"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","article-title":"Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism","volume":"29","author":"Omura","year":"2006","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib35","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.002_bib38","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib39","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib40","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/HJH.0000000000000367","article-title":"Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications","volume":"33","author":"Berge","year":"2015","journal-title":"J Hypertens"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.002_bib42","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","article-title":"Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma","volume":"85","author":"Phillips","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.002_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF00577740","article-title":"Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands","volume":"72","author":"Jeck","year":"1994","journal-title":"Clin Investig"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","article-title":"Diagnosis of primary aldosteronism: from screening to subtype differentiation","volume":"16","author":"Mulatero","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ackd.2015.03.002_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/RCT.0000000000000208","article-title":"Diagnostic performance of multidetector computed tomography in distinguishing unilateral from bilateral abnormalities in primary hyperaldosteronism: comparison of multidetector computed tomography with adrenal vein sampling","author":"Raman","year":"2015","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"issue":"10","key":"10.1053\/j.ackd.2015.03.002_bib48","first-page":"1326","article-title":"Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism","volume":"26","author":"Nocaudie-Calzada","year":"1999","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2265.2009.03714.x","article-title":"Adrenal vein sampling for primary aldosteronism: time for a reality check","volume":"72","author":"Stewart","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s11255-008-9441-9","article-title":"Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling","volume":"40","author":"Kline","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1053\/j.ackd.2015.03.002_bib53","article-title":"Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy","author":"Volpe","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00423-009-0498-4","article-title":"Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism","volume":"395","author":"Hennings","year":"2010","journal-title":"Langenbecks Arch Surg"},{"issue":"893","key":"10.1053\/j.ackd.2015.03.002_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/pmj.76.893.160","article-title":"Recurrence of adrenal aldosterone-producing adenoma","volume":"76","author":"Calvo-Romero","year":"2000","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.surg.2014.08.019","article-title":"Aldosteronoma resolution score predicts long-term resolution of hypertension","volume":"156","author":"Aronova","year":"2014","journal-title":"Surgery"},{"issue":"10","key":"10.1053\/j.ackd.2015.03.002_bib58","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1007\/s00268-014-2612-1","article-title":"Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism","volume":"38","author":"Utsumi","year":"2014","journal-title":"World J Surg"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review","volume":"44","author":"Steichen","year":"2012","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib60","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF02067355","article-title":"Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients","volume":"16","author":"Favia","year":"1992","journal-title":"World J Surg"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.12497","article-title":"Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism","volume":"81","author":"Tanase-Nakao","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/iju.12029","article-title":"Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy","volume":"20","author":"Utsumi","year":"2013","journal-title":"Int J Urol"},{"issue":"25","key":"10.1053\/j.ackd.2015.03.002_bib63","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","article-title":"Primary aldosteronism","volume":"339","author":"Ganguly","year":"1998","journal-title":"N Engl J Med"},{"issue":"6938","key":"10.1053\/j.ackd.2015.03.002_bib64","first-page":"335","article-title":"Primary aldosteronism due to adrenocortical hyperplasia","volume":"271","author":"Doorenbos","year":"1956","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.002_bib66","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.002_bib68","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib69","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib70","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib71","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","article-title":"Primary aldosteronism: diagnosis, localization, and treatment","volume":"90","author":"Weinberger","year":"1979","journal-title":"Ann Intern Med"},{"issue":"6357","key":"10.1053\/j.ackd.2015.03.002_bib72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib73","first-page":"329","article-title":"Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland","volume":"46","author":"Adler","year":"2005","journal-title":"J Appl Genet"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.jhh.1001821","article-title":"Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting","volume":"19","author":"Pizzolo","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.002_bib75","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.110.168740","article-title":"Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation","volume":"57","author":"Aglony","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib76","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI118279","article-title":"Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree","volume":"96","author":"Pascoe","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood","volume":"138","author":"Dluhy","year":"2001","journal-title":"J Pediatr"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib79","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1542\/peds.65.3.597","article-title":"Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism","volume":"65","author":"Grim","year":"1980","journal-title":"Pediatrics"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib80","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ndt\/gfl706","article-title":"A German family with glucocorticoid-remediable aldosteronism","volume":"22","author":"Vonend","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","article-title":"The changing clinical spectrum of primary aldosteronism","volume":"74","author":"Bravo","year":"1983","journal-title":"Am J Med"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib82","first-page":"1507","article-title":"Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism","volume":"82","author":"Litchfield","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1053\/j.ackd.2015.03.002_bib83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1 Pt 2","key":"10.1053\/j.ackd.2015.03.002_bib84","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J Vasc Res"},{"key":"10.1053\/j.ackd.2015.03.002_bib86","first-page":"285","article-title":"Hypertension and hyperalimentation. I. Aldosterone hypertension","volume":"14","author":"Hall","year":"1965","journal-title":"Lab Invest"},{"issue":"9","key":"10.1053\/j.ackd.2015.03.002_bib87","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0895-4356(91)90056-F","article-title":"Risk factors for subarachnoid hemorrhage in a longitudinal population study","volume":"44","author":"Knekt","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.1983.tb02880.x","article-title":"Malignant hypertension in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency","volume":"18","author":"Hague","year":"1983","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.002_bib89","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM198103193041203","article-title":"The natural history of unruptured intracranial aneurysms","volume":"304","author":"Wiebers","year":"1981","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM199401203300305","article-title":"Brief report: Liddle's syndrome revisited\u2013a disorder of sodium reabsorption in the distal tubule","volume":"330","author":"Botero-Velez","year":"1994","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.ackd.2015.03.002_bib91","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM199209243271303","article-title":"Intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"327","author":"Chapman","year":"1992","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib92","first-page":"3570","article-title":"Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism","volume":"82","author":"Litchfield","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib93","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib94","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1053\/j.ackd.2015.03.002_bib95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mce.2003.10.056","article-title":"Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production","volume":"214","author":"Nicod","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000326524","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children","volume":"76","author":"Kamrath","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.002_bib97","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","article-title":"Glucocorticoid-remediable aldosteronism","volume":"40","author":"Halperin","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib99","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"10.1053\/j.ackd.2015.03.002_bib100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cca.2014.05.015","article-title":"Molecular genetics of Liddle's syndrome","volume":"436","author":"Yang","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib102","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","article-title":"Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel","volume":"79","author":"Shimkets","year":"1994","journal-title":"Cell"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib103","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-52-5-1027","article-title":"The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome","volume":"52","author":"Wang","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9343(98)00018-7","article-title":"Liddle's syndrome","volume":"104","author":"Palmer","year":"1998","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib105","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI118606","article-title":"Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene","volume":"97","author":"Tamura","year":"1996","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib106","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-44-5-924","article-title":"Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension","volume":"44","author":"New","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib107","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1681\/ASN.2006060570","article-title":"Apparent mineralocorticoid excess: report of six new cases and extensive personal experience","volume":"17","author":"Morineau","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2015.03.002_bib108","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.4158\/EP14094.CR","article-title":"Apparent mineralocorticoid excess caused by a novel mutation in 11-beta hydroxysteroid dehydrogenase type 2 enzyme: its genetics and response to therapy","volume":"20","author":"Alzahrani","year":"2014","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib109","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1291\/hypres.29.243","article-title":"Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense\/frameshift mutations","volume":"29","author":"Kamide","year":"2006","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.002_bib110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.002_bib111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends Endocrinol Metabol"},{"issue":"1-2","key":"10.1053\/j.ackd.2015.03.002_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s004670000377","article-title":"Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome","volume":"15","author":"Moudgil","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.002_bib113","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03343755","article-title":"Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?","volume":"23","author":"Palermo","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"24","key":"10.1053\/j.ackd.2015.03.002_bib114","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJM199812103392414","article-title":"Cure of apparent mineralocorticoid excess by kidney transplantation","volume":"339","author":"Palermo","year":"1998","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1053\/j.ackd.2015.03.002_bib115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism","volume":"325","author":"Farese","year":"1991","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ackd.2015.03.002_bib116","first-page":"5222","article-title":"Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension?","volume":"86","author":"Heilmann","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.002_bib117","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0032-1321851","article-title":"11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension","volume":"44","author":"Melcescu","year":"2012","journal-title":"Horm Metab Res"},{"issue":"9","key":"10.1053\/j.ackd.2015.03.002_bib118","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1210\/jc.2005-1145","article-title":"Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews","volume":"90","author":"Paperna","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.002_bib119","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI115182","article-title":"A mutation in CYP11B1 (Arg-448\u2013--His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin","volume":"87","author":"White","year":"1991","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.002_bib120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/edrv-12-1-91","article-title":"17 alpha-hydroxylase\/17,20-lyase deficiency: from clinical investigation to molecular definition","volume":"12","author":"Yanase","year":"1991","journal-title":"Endocr Rev"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T16:03:30Z","timestamp":1651766610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559515000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1548559515000385"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2015.03.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"type":"print","value":"1548-5595"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}